Article
The global succinylation of SARS-CoV-2–infected host cells reveals drug targets
12 Jul 2022
Abstract excerpt
SARS-CoV-2, the causative agent of the COVID-19 pandemic, undergoes continuous evolution, highlighting an urgent need for development of novel antiviral therapies. Here we show a quantitative mass spectrometry-based succinylproteomics analysis of SARS-CoV-2 infection in Caco-2 cells, revealing dramatic reshape of succinylation on host and viral proteins. SARS-CoV-2 infection promotes succinylation of several key...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
